The All.Can initiative was set up to engage policymakers on the need to improve the efficiency of cancer care, focusing on better outcomes for patients – and to try to identify ways to optimise the use of resources in cancer care. IBTA Chair Kathy Oliver is a member of the All.Can initiative, as are leading cancer experts from the patient advocacy, medical, academic and industry spheres.
The report brings together powerful examples across all aspects of cancer care where there is opportunity for greater efficiency – and a more patient-focused approach. It concludes with a call to action to policymakers to focus political will and take a long-term, holistic view of cancer care, invest in data and instil appropriate mechanisms across all aspects of cancer care planning, delivery and evaluation to ensure that efforts are always focused on measurable patient outcomes.
To access the report, see www.all-can.org under Publications.
The All.Can initiative is made possible with financial support from Bristol-Myers Squibb (lead sponsor), Amgen and MSD (co-sponsors).